Employers › Dr. Reddy's Laboratories
Recordkeeping fees per participant · DR. Reddy's Laboratories Inc. 401(k) Profit Sharing Plan · plan year 2024
$88.10
Higher than 65% of the 5,847 plans $50 to 250M that report it.
= $60,962 / 692
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251013144204NAL0003235586001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013144204NAL0003235586001, received 2025-10-13
Percentiles compare this plan with the Schedule H plans $50 to 250M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-13.
Administrative expenses excluding investment management, per participant
$247.98
Higher than 90% of the 8,758 plans $50 to 250M that report it.
= $171,602 / 692
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251013144204NAL0003235586001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013144204NAL0003235586001, received 2025-10-13
Administrative expenses per participant
$267.92
Higher than 83% of the 9,042 plans $50 to 250M that report it.
= $185,399 / 692
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251013144204NAL0003235586001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013144204NAL0003235586001, received 2025-10-13
Administrative expenses as a share of assets
0.214%
Higher than 73% of the 9,049 plans $50 to 250M that report it.
= $185,399 / $86,663,583
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251013144204NAL0003235586001, received 2025-10-13
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251013144204NAL0003235586001, received 2025-10-13
Employer contributions per participant
$4,012
Higher than 69% of the 9,105 plans $50 to 250M that report it.
= $2,776,626 / 692
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251013144204NAL0003235586001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013144204NAL0003235586001, received 2025-10-13
Employer share of total contributions
38.5%
Higher than 74% of the 9,112 plans $50 to 250M that report it.
= $2,776,626 / $7,209,152
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251013144204NAL0003235586001, received 2025-10-13
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251013144204NAL0003235586001, received 2025-10-13
Plan terms are not published in public filings.
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2R participant brokerage window · 2T default investment (QDIA) · 3D IRS pre-approved plan · 3H controlled-group sponsor · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251013144204NAL0003235586001, received 2025-10-13
| Field | Value | Source |
|---|---|---|
| Plan sponsor | DR REDDY'S LABORATORIES INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Plan name | DR. REDDY'S LABORATORIES INC. 401(K) PROFIT SHARING PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Sponsor EIN / plan number | 22-3181573 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Sponsor location | PRINCETON, NJ | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Industry (business code) | 424210, Wholesale trade | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Filing received | 2025-10-13 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Participants, beginning of year | 715 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Active participants | 409 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Participants, end of year | 741 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Participants with an account balance | 692 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Total assets, beginning of year | $77,726,832 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Total assets, end of year | $86,663,583 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Net assets, end of year | $86,663,583 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Total income | $18,434,402 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Net income | $8,936,751 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Employer contributions | $2,776,626 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Participant contributions | $4,154,126 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Other contributions (incl. rollovers) | $278,400 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Total contributions | $7,209,152 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Benefit payments | $9,311,381 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Total expenses (incl. benefit payments) | $9,497,651 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Total administrative expenses | $185,399 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Contract administrator fees | $1,500 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Recordkeeping fees | $60,962 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| IQPA audit fees | $23,920 | Schedule H, line 2i(4); IQPA_AUDIT_FEES_AMT pos 161; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Investment advisory and management fees | $13,797 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Administrative expenses excluding investment management | $171,602 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Held in master trusts | $0 | Schedule H, line 1c(11) col (b); INT_MASTER_TR_EOY_AMT pos 53; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Held in common/collective trusts | $2,959,866 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Held in mutual funds | $78,539,124 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251013144204NAL0003235586001, received 2025-10-13 |
| Independent auditor | FORVIS MAZARS, LLP | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251013144204NAL0003235586001, received 2025-10-13 |
Position = column in the DOL layout for form year 2024. Filing 20251013144204NAL0003235586001, received 2025-10-13.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| FIDELITY INVESTMENTS INSTITUTIONALrecordkeeper | RECORDKEEPER | 37 Participant loan processing; 60 Sub-transfer agency fees; 64 Recordkeeping fees; 65 Account maintenance fees; 71 Securities brokerage commissions and fees | $62,464 | yes |
| ALLIANT | INVESTMENT ADVISOR | 16 Consulting (general); 27 Investment advisory (plan) | $43,750 | no |
| FORVIS MAZARS, LLP | ACCOUNTANT/AUDITOR | 10 Accounting (including auditing) | $23,920 | no |
| STRATEGIC ADVISORS, INC. | ADVISOR | 27 Investment advisory (plan) | $13,797 | no |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251013144204NAL0003235586001, received 2025-10-13.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $77,726,832 | $86,663,583 | 11.5% |
| Participants with a balance | 712 | 692 | -2.8% |
| Administrative expenses | $114,084 | $185,399 | 62.5% |
| Recordkeeping fees per participant | $111.69 | $88.10 | -21.1% |
| Employer contributions | $2,585,458 | $2,776,626 | 7.4% |
Prior filing 20241014092222NAL0025811585001, received 2024-10-14; the plan years are contiguous.
Sponsor name as filed: DR REDDY'S LABORATORIES INC.; SEC registrant: Dr. Reddy's Laboratories, Inc. (CIK 2117529, matched by EIN).